Andrew Booth - 09 Jun 2021 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Role
Chief Financial Officer
Signature
/s/ Tryn Stimart, attorney-in-fact
Issuer symbol
ABCL
Transactions as of
09 Jun 2021
Transactions value $
-$30,600,000
Form type
4
Filing time
10 Jun 2021, 17:00:48 UTC
Previous filing
09 Jun 2021
Next filing
15 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABCL Common Shares Sale -$30.6M -1.2M -100% $25.50* 0 09 Jun 2021 Direct F1
holding ABCL Common Shares 117K 09 Jun 2021 By spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 9, 2021, the shares were sold in connection with a private sale transaction at a per share price of $25.50.